AUROBINDO PHARMA (India) Today

Equity ratings for AUROBINDO PHARMA LTD are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 2nd of July 2021 and ending today, the 29th of November 2021. Click here to learn more.
AUROBINDO PHARMA LTD cannot be verified against its exchange. It appears that AUROBINDO PHARMA is not available for investing at the moment. Please verify the symbol is currently traded on Bombay Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

AUROBINDO PHARMA Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. AUROBINDO PHARMA's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding AUROBINDO PHARMA or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
AUROBINDO PHARMA LTD is not yet fully synchronised with the market data
AUROBINDO PHARMA LTD has some characteristics of a very speculative penny stock
AUROBINDO PHARMA LTD has high likelihood to experience some financial distress in the next 2 years
Legal NameAUROBINDO PHARMA LTD
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of AUROBINDO PHARMA's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
AUROBINDO PHARMA LTD (AUROPHARMA) is traded on Bombay Stock Exchange in India and employs 19,000 people. The company currently falls under 'Mega-Cap' category with current market capitalization of 400.35 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AUROBINDO PHARMA's market, we take the total number of its shares issued and multiply it by AUROBINDO PHARMA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. AUROBINDO PHARMA LTD operates under Healthcare sector and is part of Drug Manufacturers - Specialty & Generic industry. The entity has 585.92 M outstanding shares.
Check AUROBINDO PHARMA Probability Of Bankruptcy

AUROBINDO Stock Against Markets

Picking the right benchmark for AUROBINDO PHARMA stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in AUROBINDO PHARMA stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for AUROBINDO PHARMA is critical whether you are bullish or bearish towards AUROBINDO PHARMA LTD at a given time.
AUROBINDO PHARMA LTD cannot be verified against its exchange. It appears that AUROBINDO PHARMA is not available for investing at the moment. Please verify the symbol is currently traded on Bombay Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with AUROBINDO PHARMA stock to make a market-neutral strategy. Peer analysis of AUROBINDO PHARMA could also be used in its relative valuation, which is a method of valuing AUROBINDO PHARMA by comparing valuation metrics with similar companies.
Check out Trending Equities. Note that the AUROBINDO PHARMA LTD information on this page should be used as a complementary analysis to other AUROBINDO PHARMA's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Tools for AUROBINDO Stock

When running AUROBINDO PHARMA LTD price analysis, check to measure AUROBINDO PHARMA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AUROBINDO PHARMA is operating at the current time. Most of AUROBINDO PHARMA's value examination focuses on studying past and present price action to predict the probability of AUROBINDO PHARMA's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move AUROBINDO PHARMA's price. Additionally, you may evaluate how the addition of AUROBINDO PHARMA to your portfolios can decrease your overall portfolio volatility.
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go